Skip to main content
. 2014 Nov 5;5:561. doi: 10.3389/fimmu.2014.00561

Figure 6.

Figure 6

Relative inhibitory effect of HSA–Trx or Tamiflu® on influenza-infected mice. HSA–Trx (3.5 nmol/mouse) was administered intravenously at 4 and 6 days after virus infection. Tamiflu® (5 mg/kg) was administrated intraperitonealy every day at 2 times per day for a total of 4 days starting on 2 day after the influenza infection. The numbers of (A) total cells and (B) neutrophils, or (C) protein concentration in BALF were determined at 8 days after virus infection. (D) Sections of pulmonary tissue were prepared at 8 days after virus infection, and subjected to histopathological examination (HE staining). Magnifications: ×40 in (D); ×200 in (E). Each value represents the mean ± SE (n = 5). *P < 0.05 and **P < 0.01 as compared with saline. #P < 0.05 as compared with HSA–Trx.